nodes	percent_of_prediction	percent_of_DWPC	metapath
Telavancin—Necrosis—Calcium Acetate—osteoporosis	0.0458	0.0458	CcSEcCtD
Telavancin—Abscess—Calcium Acetate—osteoporosis	0.0454	0.0454	CcSEcCtD
Telavancin—Venous thrombosis—Estropipate—osteoporosis	0.0378	0.0378	CcSEcCtD
Telavancin—Venous thrombosis—Conjugated Estrogens—osteoporosis	0.025	0.025	CcSEcCtD
Telavancin—Fluid overload—Pamidronate—osteoporosis	0.0247	0.0247	CcSEcCtD
Telavancin—Tenderness—Estropipate—osteoporosis	0.0234	0.0234	CcSEcCtD
Telavancin—Tenderness—Raloxifene—osteoporosis	0.0227	0.0227	CcSEcCtD
Telavancin—Fluid overload—Conjugated Estrogens—osteoporosis	0.0217	0.0217	CcSEcCtD
Telavancin—Ulcer—Alendronate—osteoporosis	0.0213	0.0213	CcSEcCtD
Telavancin—Ulcer—Ibandronate—osteoporosis	0.0207	0.0207	CcSEcCtD
Telavancin—Necrosis—Conjugated Estrogens—osteoporosis	0.0172	0.0172	CcSEcCtD
Telavancin—Ulcer—Risedronate—osteoporosis	0.0171	0.0171	CcSEcCtD
Telavancin—Abscess—Conjugated Estrogens—osteoporosis	0.017	0.017	CcSEcCtD
Telavancin—Extravasation—Conjugated Estrogens—osteoporosis	0.0155	0.0155	CcSEcCtD
Telavancin—Tenderness—Conjugated Estrogens—osteoporosis	0.0155	0.0155	CcSEcCtD
Telavancin—Hyperkalaemia—Pamidronate—osteoporosis	0.0151	0.0151	CcSEcCtD
Telavancin—Ulcer—Conjugated Estrogens—osteoporosis	0.0143	0.0143	CcSEcCtD
Telavancin—Hyperkalaemia—Zoledronate—osteoporosis	0.0138	0.0138	CcSEcCtD
Telavancin—Phlebitis—Pamidronate—osteoporosis	0.0129	0.0129	CcSEcCtD
Telavancin—Tenderness—Estradiol—osteoporosis	0.0124	0.0124	CcSEcCtD
Telavancin—Abdominal discomfort—Estropipate—osteoporosis	0.0123	0.0123	CcSEcCtD
Telavancin—Abdominal discomfort—Alendronate—osteoporosis	0.0121	0.0121	CcSEcCtD
Telavancin—Abdominal discomfort—Ibandronate—osteoporosis	0.0118	0.0118	CcSEcCtD
Telavancin—Ulcer—Estradiol—osteoporosis	0.0114	0.0114	CcSEcCtD
Telavancin—Phlebitis—Conjugated Estrogens—osteoporosis	0.0114	0.0114	CcSEcCtD
Telavancin—Gastrointestinal haemorrhage—Pamidronate—osteoporosis	0.0111	0.0111	CcSEcCtD
Telavancin—Flatulence—Etidronic acid—osteoporosis	0.0102	0.0102	CcSEcCtD
Telavancin—Abdominal discomfort—Risedronate—osteoporosis	0.0097	0.0097	CcSEcCtD
Telavancin—Phlebitis—Estradiol—osteoporosis	0.0091	0.0091	CcSEcCtD
Telavancin—Flatulence—Estropipate—osteoporosis	0.00879	0.00879	CcSEcCtD
Telavancin—Diarrhoea—Calcium Acetate—osteoporosis	0.00877	0.00877	CcSEcCtD
Telavancin—Flatulence—Alendronate—osteoporosis	0.00866	0.00866	CcSEcCtD
Telavancin—Flatulence—Raloxifene—osteoporosis	0.00852	0.00852	CcSEcCtD
Telavancin—Flatulence—Ibandronate—osteoporosis	0.00843	0.00843	CcSEcCtD
Telavancin—Abdominal discomfort—Zoledronate—osteoporosis	0.00842	0.00842	CcSEcCtD
Telavancin—Infection—Etidronic acid—osteoporosis	0.00836	0.00836	CcSEcCtD
Telavancin—Vomiting—Calcium Acetate—osteoporosis	0.00815	0.00815	CcSEcCtD
Telavancin—Abdominal discomfort—Conjugated Estrogens—osteoporosis	0.00811	0.00811	CcSEcCtD
Telavancin—Nausea—Calcium Acetate—osteoporosis	0.00762	0.00762	CcSEcCtD
Telavancin—Infection—Estropipate—osteoporosis	0.00724	0.00724	CcSEcCtD
Telavancin—Infection—Alendronate—osteoporosis	0.00713	0.00713	CcSEcCtD
Telavancin—Infection—Raloxifene—osteoporosis	0.00701	0.00701	CcSEcCtD
Telavancin—Flatulence—Risedronate—osteoporosis	0.00695	0.00695	CcSEcCtD
Telavancin—Infection—Ibandronate—osteoporosis	0.00694	0.00694	CcSEcCtD
Telavancin—Nausea—Ergocalciferol—osteoporosis	0.00673	0.00673	CcSEcCtD
Telavancin—Abdominal discomfort—Estradiol—osteoporosis	0.00649	0.00649	CcSEcCtD
Telavancin—Infection—Ethinyl Estradiol—osteoporosis	0.00586	0.00586	CcSEcCtD
Telavancin—Flatulence—Conjugated Estrogens—osteoporosis	0.00581	0.00581	CcSEcCtD
Telavancin—Diarrhoea—Etidronic acid—osteoporosis	0.00576	0.00576	CcSEcCtD
Telavancin—Body temperature increased—Estropipate—osteoporosis	0.00576	0.00576	CcSEcCtD
Telavancin—Infection—Risedronate—osteoporosis	0.00572	0.00572	CcSEcCtD
Telavancin—Body temperature increased—Alendronate—osteoporosis	0.00567	0.00567	CcSEcCtD
Telavancin—Body temperature increased—Raloxifene—osteoporosis	0.00558	0.00558	CcSEcCtD
Telavancin—Body temperature increased—Ibandronate—osteoporosis	0.00552	0.00552	CcSEcCtD
Telavancin—Infection—Pamidronate—osteoporosis	0.00544	0.00544	CcSEcCtD
Telavancin—Body temperature increased—Calcitriol—osteoporosis	0.0054	0.0054	CcSEcCtD
Telavancin—Vomiting—Etidronic acid—osteoporosis	0.00535	0.00535	CcSEcCtD
Telavancin—Rash—Etidronic acid—osteoporosis	0.00531	0.00531	CcSEcCtD
Telavancin—Dermatitis—Etidronic acid—osteoporosis	0.0053	0.0053	CcSEcCtD
Telavancin—Nausea—Etidronic acid—osteoporosis	0.005	0.005	CcSEcCtD
Telavancin—Diarrhoea—Estropipate—osteoporosis	0.00498	0.00498	CcSEcCtD
Telavancin—Infection—Zoledronate—osteoporosis	0.00496	0.00496	CcSEcCtD
Telavancin—Diarrhoea—Alendronate—osteoporosis	0.00491	0.00491	CcSEcCtD
Telavancin—Diarrhoea—Raloxifene—osteoporosis	0.00483	0.00483	CcSEcCtD
Telavancin—Infection—Conjugated Estrogens—osteoporosis	0.00478	0.00478	CcSEcCtD
Telavancin—Diarrhoea—Ibandronate—osteoporosis	0.00478	0.00478	CcSEcCtD
Telavancin—Diarrhoea—Calcitriol—osteoporosis	0.00468	0.00468	CcSEcCtD
Telavancin—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00467	0.00467	CcSEcCtD
Telavancin—Flatulence—Estradiol—osteoporosis	0.00465	0.00465	CcSEcCtD
Telavancin—Vomiting—Estropipate—osteoporosis	0.00463	0.00463	CcSEcCtD
Telavancin—Rash—Estropipate—osteoporosis	0.00459	0.00459	CcSEcCtD
Telavancin—Dermatitis—Estropipate—osteoporosis	0.00459	0.00459	CcSEcCtD
Telavancin—Vomiting—Alendronate—osteoporosis	0.00456	0.00456	CcSEcCtD
Telavancin—Body temperature increased—Risedronate—osteoporosis	0.00455	0.00455	CcSEcCtD
Telavancin—Rash—Alendronate—osteoporosis	0.00452	0.00452	CcSEcCtD
Telavancin—Dermatitis—Alendronate—osteoporosis	0.00452	0.00452	CcSEcCtD
Telavancin—Vomiting—Raloxifene—osteoporosis	0.00449	0.00449	CcSEcCtD
Telavancin—Rash—Raloxifene—osteoporosis	0.00445	0.00445	CcSEcCtD
Telavancin—Dermatitis—Raloxifene—osteoporosis	0.00444	0.00444	CcSEcCtD
Telavancin—Vomiting—Ibandronate—osteoporosis	0.00444	0.00444	CcSEcCtD
Telavancin—Rash—Ibandronate—osteoporosis	0.0044	0.0044	CcSEcCtD
Telavancin—Dermatitis—Ibandronate—osteoporosis	0.0044	0.0044	CcSEcCtD
Telavancin—Vomiting—Calcitriol—osteoporosis	0.00435	0.00435	CcSEcCtD
Telavancin—Nausea—Estropipate—osteoporosis	0.00433	0.00433	CcSEcCtD
Telavancin—Body temperature increased—Pamidronate—osteoporosis	0.00433	0.00433	CcSEcCtD
Telavancin—Rash—Calcitriol—osteoporosis	0.00431	0.00431	CcSEcCtD
Telavancin—Dermatitis—Calcitriol—osteoporosis	0.00431	0.00431	CcSEcCtD
Telavancin—Nausea—Alendronate—osteoporosis	0.00426	0.00426	CcSEcCtD
Telavancin—Nausea—Raloxifene—osteoporosis	0.00419	0.00419	CcSEcCtD
Telavancin—Nausea—Ibandronate—osteoporosis	0.00415	0.00415	CcSEcCtD
Telavancin—Nausea—Calcitriol—osteoporosis	0.00406	0.00406	CcSEcCtD
Telavancin—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00404	0.00404	CcSEcCtD
Telavancin—Body temperature increased—Zoledronate—osteoporosis	0.00395	0.00395	CcSEcCtD
Telavancin—Diarrhoea—Risedronate—osteoporosis	0.00394	0.00394	CcSEcCtD
Telavancin—Infection—Estradiol—osteoporosis	0.00383	0.00383	CcSEcCtD
Telavancin—Body temperature increased—Conjugated Estrogens—osteoporosis	0.0038	0.0038	CcSEcCtD
Telavancin—Vomiting—Ethinyl Estradiol—osteoporosis	0.00375	0.00375	CcSEcCtD
Telavancin—Diarrhoea—Pamidronate—osteoporosis	0.00374	0.00374	CcSEcCtD
Telavancin—Rash—Ethinyl Estradiol—osteoporosis	0.00372	0.00372	CcSEcCtD
Telavancin—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00372	0.00372	CcSEcCtD
Telavancin—Vomiting—Risedronate—osteoporosis	0.00366	0.00366	CcSEcCtD
Telavancin—Rash—Risedronate—osteoporosis	0.00363	0.00363	CcSEcCtD
Telavancin—Dermatitis—Risedronate—osteoporosis	0.00363	0.00363	CcSEcCtD
Telavancin—Nausea—Ethinyl Estradiol—osteoporosis	0.00351	0.00351	CcSEcCtD
Telavancin—Vomiting—Pamidronate—osteoporosis	0.00348	0.00348	CcSEcCtD
Telavancin—Rash—Pamidronate—osteoporosis	0.00345	0.00345	CcSEcCtD
Telavancin—Dermatitis—Pamidronate—osteoporosis	0.00345	0.00345	CcSEcCtD
Telavancin—Diarrhoea—Zoledronate—osteoporosis	0.00342	0.00342	CcSEcCtD
Telavancin—Nausea—Risedronate—osteoporosis	0.00342	0.00342	CcSEcCtD
Telavancin—Diarrhoea—Conjugated Estrogens—osteoporosis	0.00329	0.00329	CcSEcCtD
Telavancin—Nausea—Pamidronate—osteoporosis	0.00325	0.00325	CcSEcCtD
Telavancin—Vomiting—Zoledronate—osteoporosis	0.00318	0.00318	CcSEcCtD
Telavancin—Rash—Zoledronate—osteoporosis	0.00315	0.00315	CcSEcCtD
Telavancin—Dermatitis—Zoledronate—osteoporosis	0.00315	0.00315	CcSEcCtD
Telavancin—Vomiting—Conjugated Estrogens—osteoporosis	0.00306	0.00306	CcSEcCtD
Telavancin—Body temperature increased—Estradiol—osteoporosis	0.00304	0.00304	CcSEcCtD
Telavancin—Rash—Conjugated Estrogens—osteoporosis	0.00303	0.00303	CcSEcCtD
Telavancin—Dermatitis—Conjugated Estrogens—osteoporosis	0.00303	0.00303	CcSEcCtD
Telavancin—Nausea—Zoledronate—osteoporosis	0.00297	0.00297	CcSEcCtD
Telavancin—Nausea—Conjugated Estrogens—osteoporosis	0.00286	0.00286	CcSEcCtD
Telavancin—Diarrhoea—Estradiol—osteoporosis	0.00264	0.00264	CcSEcCtD
Telavancin—Vomiting—Estradiol—osteoporosis	0.00245	0.00245	CcSEcCtD
Telavancin—Rash—Estradiol—osteoporosis	0.00243	0.00243	CcSEcCtD
Telavancin—Dermatitis—Estradiol—osteoporosis	0.00243	0.00243	CcSEcCtD
Telavancin—Nausea—Estradiol—osteoporosis	0.00229	0.00229	CcSEcCtD
